Related Experiment Videos

Are there more tumor necrosis factors?

M A Palladino¹

¹Genentech, Inc., South San Francisco, CA 94080.

Journal of the National Cancer Institute

|April 5, 1989

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials.

Current cancer drug targets·2011

Normoxic expression of hypoxia-inducible factor 1 in rat Leydig cells in vivo and in vitro.

Journal of andrology·2010

Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cells.

Oncogene·2010

Members of the Toll-like receptor family of innate immunity pattern-recognition receptors are abundant in the male rat reproductive tract.

Biology of reproduction·2007

Oncologic emergencies secondary to advanced colorectal cancer successfully treated with oxaliplatin/5-fluorouracil/leucovorin: report of three cases.

Journal of chemotherapy (Florence, Italy)·2005

See all related articles